**Author details**

#### Isaac Karimi

*Division of Biochemistry, Physiology and Pharmacology, Department of Basic Veterinary Sciences, School of Veterinary Medicine, Razi University, Kermanshah, Iran* 

#### **5. References**

	- [3] Haller H (1977) Epidermiology and associated risk factors of hyperlipoproteinemia. Z Gesamte Inn Med. 15;32(8):124-8. [Article in German]
	- [4] Phillips GB (1978) Sex hormones, risk factors and cardiovascular disease. Am J Med. 65:7-11.
	- [5] Phillips GB (1977) Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci USA*.*74: 1729-1733.
	- [6] Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595–1607.
	- [7] World Health Organization (1999) WHO consultation: definition, diagnosis and clasification of diabetes mellitus and its complications. Geneva: WHO.
	- [8] Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome: a new worldwide definition. Lancet. 24; 366:1059–62.
	- [9] Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med.16:442–3.
	- [10] Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA.285:2486–97.
	- [11] Cziraky MJ (2004) Management of dyslipidemia in patients with metabolic syndrome. J Am Pharm Assoc. 44: 478-488.
	- [12] Srinivasan K, Ramarao P (2007) Animal models in type 2 diabetes research: An overview. Indian J Med Res. 125: 451-472
	- [13] Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med.350:2362–74.
	- [14] Bruce KD, Byrne CD (2009) The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J. 85:614–621.
	- [15] Getz GS, Reardon CA (2006) Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol. 26:242-249.
	- [16] Maxwell KN, Soccio RE, Duncan EM, Sehayek E, Breslow JL (2003) Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterolfed mice. J Lipid Res. 44:2109-2119.
	- [17] Nishina PM, Lowe S, Verstuyft J, Naggert JK, Kuypers FA, Paigen B (1993) Effects of dietary fats from animal and plant sources on diet-induced fatty streak lesions in C57BL/6J mice. J Lipid Res. 34:1413-1422.
	- [18] Cefalu WT (2006) Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. ILAR J. 47(3).
	- [19] Panchal SK, Brown L (2011) Rodent models for metabolic syndrome research. J Biomed Biotechnol. 2011:351982.
	- [20] Kobayasi R, Akamine EH, Davel AP, Rodrigues MAM, Carvalho CRO and Rossoni LV (2010) "Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice," J Hypertension. 28: 2111–2119.

[21] Deji N, Kume S, Araki SI et al (2009) "Structural and functional changes in the kidneys of high-fat diet-induced obese mice,". Am J Physio. 296: F118–F126.

524 Lipoproteins – Role in Health and Diseases

Diabetes 37: 1595–1607.

definition. Lancet. 24; 366:1059–62.

Am Pharm Assoc. 44: 478-488.

Vasc Biol. 26:242-249.

Biotechnol. 2011:351982.

fed mice. J Lipid Res. 44:2109-2119.

C57BL/6J mice. J Lipid Res. 34:1413-1422.

overview. Indian J Med Res. 125: 451-472

65:7-11.

1729-1733.

Med.16:442–3.

[3] Haller H (1977) Epidermiology and associated risk factors of hyperlipoproteinemia. Z

[4] Phillips GB (1978) Sex hormones, risk factors and cardiovascular disease. Am J Med.

[5] Phillips GB (1977) Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci USA*.*74:

[6] Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease.

[7] World Health Organization (1999) WHO consultation: definition, diagnosis and

[8] Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome: a new worldwide

[9] Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet

[10] Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation, And Treatment of High

[12] Srinivasan K, Ramarao P (2007) Animal models in type 2 diabetes research: An

[13] Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S (2004) Obesity and the metabolic

[14] Bruce KD, Byrne CD (2009) The metabolic syndrome: common origins of a

[15] Getz GS, Reardon CA (2006) Diet and murine atherosclerosis. Arterioscler Thromb

[16] Maxwell KN, Soccio RE, Duncan EM, Sehayek E, Breslow JL (2003) Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-

[17] Nishina PM, Lowe S, Verstuyft J, Naggert JK, Kuypers FA, Paigen B (1993) Effects of dietary fats from animal and plant sources on diet-induced fatty streak lesions in

[18] Cefalu WT (2006) Animal models of type 2 diabetes: clinical presentation and

[19] Panchal SK, Brown L (2011) Rodent models for metabolic syndrome research. J Biomed

[20] Kobayasi R, Akamine EH, Davel AP, Rodrigues MAM, Carvalho CRO and Rossoni LV (2010) "Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice," J Hypertension. 28: 2111–2119.

Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA.285:2486–97. [11] Cziraky MJ (2004) Management of dyslipidemia in patients with metabolic syndrome. J

syndrome in children and adolescents. N Engl J Med.350:2362–74.

pathophysiological relevance to the human condition. ILAR J. 47(3).

multifactorial disorder. Postgrad Med J. 85:614–621.

clasification of diabetes mellitus and its complications. Geneva: WHO.

Gesamte Inn Med. 15;32(8):124-8. [Article in German]


[53] Ballal K, Wilson CR, Harmancey R, Taegtmeyer H (2010) Obesogenic high fat western diet induces oxidative stress and apoptosis in rat heart. Mol Cell Biochem. 344(1-2):221- 30.

526 Lipoproteins – Role in Health and Diseases

Care.27:04–1496.

Heart Circ Physiol. 287:H1225–31.

Technolog Med Sci.25:243–6.

Exp. 39: 468–73.

Press. 711-732 p.

3(4):259-70.

syndrome. Brit Med Bull. 60:103–121

induced obesity. Am J Physiol. 275:E6-E11.

[36] Levin BE, Dunn-Meynell AA (2006) Differential effects of exercise on body weight gain and adiposity in obesity-prone and –resistant rats. Int J Obes(Lond). 30:722-727. [37] Levin BE, Keesey RE (1998) Defense of differing body weight set points in diet-induced

[38] Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ (2000) Development of Hypertension

[39] Krauss RM (2004) Lipids and lipoproteins in patients with type 2 diabetes. Diabetes

[40] Monti LD, Landoni C, Setola E, Galluccio E, Lucotti P, Sandoli EP, Origgi A, Lucignani G,Piatti P, Fazio F (2004) Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients. Am J Physiol

[41] Akiyama T, Tachibana I, Shirohara H, Watanabe N, Otsuki M (1996) High-fat hypercaloric diet induces obesity glucose intolerance and hyperlipidemia in normal

[42] Lauterio TJ, Barkan A, DeAngelo M, DeMott-Friberg R, Ramirez R (1998) Plasma growth hormone secretion is impaired in obesity-prone rats before onset of diet-

[43] Yang N, Wang C, Xu M, Mao L, Liu L, Sun X (2005) Interaction of dietary composition and PYY gene expression in diet-induced obesity in rats. J Huazhong Univ Sci

[44] Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS (1993)

[45] Bertram CE, Hanson MA (2001) Animal models and programming of the metabolic

[46] Guo F, Jen KLC (1995) High fat feeding during pregnancy and lactation affects

[47] Brown SA, Rogers LK, Dunn JK, Gotto AM, Jr, Patsch W (1990) Development of cholesterol homeostatic memory in the rat is influenced by maternal diets. Metab Clin

[48] Langley-Evans SC (1996) Intrauterine programming of hypertension in the rat: nutrient

[49] Ricci MR, Levin BE (2003) Ontogeny of diet-induced obesity in selectively bred Sprague-Dawley rats. Am J Physiol Regul. Integr. Comp Physiol. 285:R610-R618. [50] Corsetti JP, Sparks JD, Peterson RG, Smith RL, Sparks CE (2000) Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic

[51] Owens D (2006) Spontaneous, surgically and chemically induced models of disease. In The Laboratory Rat. Suckow MA, Weisbroth SH, Franklin CL, Eds. Elsevier Academic

[52] Blay M, Peinado-Onsurbe J, Julve J, Rodríguez V, Fernández-López JA, Remesar X, Alemany M (2001) Anomalous lipoproteins in obese Zucker rats. Diabetes Obes Metab.

Fetal nutrition and cardiovascular disease in adult life. Lancet 341: 938–941.

obese and resistant rats. Am J Physiol. 274:R412-R419.

adult male Wistar rat. Diabetes Res Clin Pract. 31: 27–35.

offspring metabolism in rats. Physiol Behav.57: 681–6

interactions. Comp Biochem Physiol. 114: 327–31

fatty male and female rats. Atherosclerosis. 148:231-241.

in a Rat Model of Diet-Induced Obesity. Hypertension.35:1009-1015.


[83] Sullivan MP, Cerda JJ, Robbins FL, Burgin CW, Beatty RJ (1993) The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. Lab Anim Sci. 43,575-578.

528 Lipoproteins – Role in Health and Diseases

Nutr Res. 16:1353-1368.

Eur J Pharmacol. 427(3):285-93.

Syrian hamsters. J Nutr.139:257–263.

trans-fatty acids. Obesity.17:1200–1207.

Frontiers in Bioscience. 8: 464-476.

22:122-129.

82:416-422.

[68] Rimando AM, Nagmani R, Feller DF, Yokoyama W (2005) Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor r-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem. 53: 3403−3407 [69] Nistor A, Bulla A, Filip DA, Radu A (1987) The hyperlipidemic hamster as a model of

[70] Kahlon T, Chow F, Irving D, Sayre R (1996) Cholesterol response and foam cell formation in hamsters fed two levels of saturated fat and various levels of cholesterol.

[71] Dillard A, Matthan NR, Lichtenstein AH (2010) Use of hamster as a model to study diet-

[72] Leung N, Naples M, Uffelman K, Szeto L, Adeli K, Lewis GF (2004) Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance. Atherosclerosis. 174(2):235-41. [73] Wang PR, Guo Q, Ippolito M, Wu M, Milot D, Ventre J, Doebber T, Wright SD, Chao YS (2001) High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists.

[74] Li S-Y, Chang C-Q, Ma F-Y, Yu C-L (2009) Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferatoractivated receptor-α in golden hamsters fed on high fat diet. Biomed Environ Sci.

[75] Tyburczy C, Major C, Lock AL, Destaillats F, Lawrence P, Brenna JT, Salter AM, Bauman DE (2009) Individual trans octadecenoic acids and partially hyrdogenated vegetable oil differentially affect hepatic lipid and lipoprotein metabolism in golden

[77] Dorfman SE, Laurent D, Gounarides JS, Li X, Mullarkey TL, Rocheford EC, Sari-Sarraf F, Hirsch EA, Hughes TE, Commerford SR (2009) Metabolic implications of dietary

[78] Costa RRS, Villela NR, Souza MdGS, Boa BCS, Cyrino FZGA, Silva SV, Lisboa PC, Moura EG, Barja-Fidalgo TC, Bouskela E (2011) High fat diet induces central obesity, insulin resistance and microvascular dysfunction in hamsters. Microvascular Res.

[79] Kothari HV, Poirier KJ, Lee WH, Satoh Y (1997) Inhibition of cholesterol ester transfer protein CGS 25159 and changes in lipoproteins in hamsters. Atherosclerosis. 128: 59-66. [80] Briand F, Thiéblemont Q, Muzotte E, Sulpice T (2012). High-Fat and Fructose Intake Induces Insulin Resistance, Dyslipidemia, and Liver Steatosis and Alters In Vivo Macrophage-to-Feces Reverse Cholesterol Transport in Hamsters. J Nutr. 142(4):704-9. [81] Bhathena J, Kulamarva A, Martoni C, Malgorzata A, Urbanska, Malhotra M, Paul A, Prakash S (2011) Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.4:195–203 [82] Avramoglu RK, Qiu W, Adeli K (2003) Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion.

[76] Kritchevsky D (2001) Diet and atherosclerosis. J Nutr Health Aging. 5:155–159.

experimental atherosclerosis. Atherosclerosis. 68:159-173.

induced Atherosclerosis. Nutr Metab. 7:89


[116] Mallidis C, Czerwiec A, Filippi S, O'Neill J, Maggi M, McClure N (2011) Spermatogenic and sperm quality differences in an experimental model of metabolic syndrome and hypogonadal hypogonadism. Reproduction. 142(1):63-71.

530 Lipoproteins – Role in Health and Diseases

Natl Acad Sci USA.87: 6204-7.

Pharm Pharmacol. 61(8):1111-8.

BMC Cardiovasc Disord. 17:7.

Voyenno-Med Akad Peter. 16:154–173.

rabbits. J Appl Biologl Sci. 4(1): 23-28.

Thromb Haemost. 86: 356-65.

Biophys Acta. 1812(8):859-66.

Biosci. 2: d298-308.

Lab Anim. 38: 246–256.

doi:10.4061/2011/364310.

Bull. 34(7): 1046-1051.

94:1838S-1845S

[99] Rath M, Pauling L (1990) Hypothesis: lipoprotein(a) is a surrogate for ascorbate. Proc

[100] Leite JO, DeOgburn R, Ratliff J, Su R, Smyth JA, Volek JS, McGrane MM, Dardik A, Fernandez ML (2010) Low-carbohydrate diets reduce lipid accumulation and arterial inflammation in guinea pigs fed a high-cholesterol diet. Atherosclerosis. 209(2):442-8. [101] Mangathayaru K, Kuruvilla S, Balakrishna K, Venkhatesh J (2009) Modulatory effect of *Inula racemosa* Hook. f. (Asteraceae) on experimental atherosclerosis in guinea-pigs. J

[102] Leite JO, Vaishnav U, Puglisi M, Fraser H, Trias J, Fernandez ML (2009) A-002 (Varespladib), a phospholipase A2 inhibitor, reduces atherosclerosis in guinea pigs.

[103] Yang R, Guo P, Song X, Liu F, Gao N (2011) Hyperlipidemic guinea pig model: mechanisms of triglyceride metabolism disorder and comparison to rat. Biol. Pharm.

[104] Evans MB, Tonini R, Shope CD, Oghalai JS, Jerger JF, Insull W Jr, Brownell WE (2006)

[105] Castañeda-Gutiérrez E, Pouteau E, Pescia G, Moulin J, Aprikian O, Macé K (2011) The guinea pig as a model for metabolic programming of adiposity. Am J Clin Nutr.

[106] Caillier B, Pilote S, Patoine D, Levac X, Couture C, Daleau P, Simard C, Drolet B (2012) Metabolic syndrome potentiates the cardiac action potential-prolonging action of drugs:

[108] Moghadasian MH, Frohlich JJ, McManus BM (2001) Advances in experimental

[109] Xiangdong L, Yuanwu L, Hua Z, Liming R, Qiuyan L, Ning L (2011) Animal models

[110] Sider KL, Blaser MC, Simmons CA (2011) Animal models of calcific aortic valve disease. International Journal of Inflammation.ID 364310, 18 pages

[111] Karimi I, Hayatgheybi H, Razmjo M, Yousefi M, Dadyan A, Hadipour MM (2010) Anti-hyperlipidaemic effects of an essential oil of *Melissa officinalis*. L in cholesterol-fed

[112] Badimon L (2001) Atherosclerosis and thrombosis: lessons from animal models.

[113] Taylor JM, Fan J (1997) Transgenic rabbit models for the study of atherosclerosis. Front

[114] Yanni AE (2004) The laboratory rabbit: an animal model of atherosclerosis research.

[115] Morelli A, Vignozzi L, Maggi M, Adorini L (2011) Farnesoid X receptor activation improves erectile dysfunction in models of metabolic syndrome and diabetes. Biochim

a possible 'anti-proarrhythmic' role for amlodipine. Pharmacol Res. 65(3):320-7. [107] Ignatowski AC (1908) Influence of animal food on the organism of rabbits. Izv Imp

Dyslipidemia and auditory function. Otol Neurotol. 27(5):609-14.

dyslipidemia and atherosclerosis. Lab Invest. 81:1173– 1183.

for the atherosclerosis research: a review. Protein Cell. 2(3):189-201.

	- [131] Clarke I (2008) Models of 'obesity' in large animals and birds. Obesity and Metabolism. 36: 107-117.
	- [132] Homan R, Hanselman JC, Bak-Mueller S, Washburn M, Lester P, Jensen HE, Pinkosky SL, Castle C, Taylor B (2010) Atherosclerosis in *Octodon degus* (degu) as a model for human disease. Atherosclerosis. 212(1):48-54.
	- [133] Shafrir E, Ziv E (1998) Cellular mechanism of nutrionally induced insulin resistance: the desert rodent *Psammomys obesus* and other animals in which insulin resistance leads to detrimental outcome. J Basic Clin Physiol Pharmacol. 9: 347-85.
	- [134] Kaiser N, Nesher R, Donath MY, Fraenkel M, Behar V, Magnan C (2005) *Psammomys obesus*, a model for environment-gene interactions in type 2 diabetes. Diabetes. 54: S137-44.
	- [135] Velasquez MT, Kimmel PL, Michaelis OE (1990) Animal models of spontaneous diabetic kidney disease. FASEB J. 4: 2850-9.
	- [136] Weir BJ (1974) The development of diabetes in the tuco-tuco (*Ctenomys talarum*). Proc R Soc Med. 67(9):843-6.
	- [137] Zhao Z-J, Chen J-F, Wang D-H (2010) Diet-induced obesity in the short-day-lean Brandt's vole. Physiol Behav. 99(1):47-53.
	- [138] Noda K, Melhorn MI, Zandi S, Frimmel S, Tayyari F, Hisatomi T, Almulki L, Pronczuk A, Hayes KC, Hafezi-Moghadam A (2010) An animal model of spontaneous metabolic syndrome: Nile grass rat. FASEB J. 24: 2443–2453.
	- [139] Roberts JC, Jr, Straus R (Eds) (1965) Comparative atherosclerosis; the morphology of spontaneous and induced atherosclerotic lesions in animals and its relation to human disease, Harper & Row, New York
	- [140] Anderson JL, Smith SC, Taylor Jr RL (2012) Spontaneous Atherosclerosis in Pigeons: A good model of human disease, atherogenesis, Prof. Sampath Parthasarathy (Ed.), ISBN: 978-953-307-992-9, InTech.
	- [141] Tigno XT, Gerzanich G, Hansen BC (2004) Age-related changes in metabolic parameters of nonhuman primates. J Gerontol A Biol Sci Med Sci. 59:1081–1088.
	- [142] Kojic ZZ (2003) Animal models in the study of atherosclerosis. Srp Arh Celok Lek. 131: 266-70.
	- [143] Wagner JD, Kavanagh K, Ward GM, Auerbach BJ, Harwood Jr HJ, Kaplan JR (2006) Old World Nonhuman Primate Models of Type 2 Diabetes Mellitus. ILAR J. 47: 259-271.
	- [144] Kusumi Y, Scanu AM, McGill HC, and Wissler RW (1993) Atherosclerosis in a rhesus monkey with genetic hypercholesterolemia and elevated plasma Lp(a). Atherosclerosis. 99:165–174.
	- [145] Pick R, Johnson PJ, Glick G (1974) Deleterious effects of hypertension on the development of aortic and coronary atherosclerosis in stumptail macaques (*Macaca speciosa*) on an atherogenic diet. Circ Res. 35: 472-82.
	- [146] Kaufman D, Smith ELP, Gohil BC, Banerji M-A, Coplan JD, Kral JG, Rosenblum LA (2005) Early Appearance of the metabolic syndrome in socially reared bonnet macaques. J Clin Endocrinol Meta. 90:404–408.
	- [147] Zhang X, Zhang R, Raab S, Zheng W, Wang J, Liu N, Zhu T, Xue L, Song Z, Mao J, Li K, Zhang H, Zhang Y, Han C, Ding Y, Wang H, Hou N, Liu Y, Shang S, Li C, Sebokova E, Cheng H, Huang PL (2011) Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone. Circulation. 124(1):77-86.
